Clinical Trial Update: Rollover Study From EXG-US-01 [Phase 1]

View source ↗

Summary

This document notes a rollover Phase 1 clinical trial from EXG-US-01 by Elixirgen Therapeutics for telomere biology disorders with bone marrow failure, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Telomere Biology Disorders with Bone Marrow Failure

Snippet

Sponsor: Elixirgen Therapeutics, Inc. | Conditions: Telomere Biology Disorders With Bone Marrow Failure | Phase 1 | Status: ENROLLING_BY_INVITATION